SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-21-039129
Filing Date
2021-03-19
Accepted
2021-03-19 16:36:15
Documents
11
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A tm218254-5_20fa.htm 20-F/A 938707
2 EXHIBIT 2.1 tm218254-5_exh2x1.htm EX-2.1 89388
3 EXHIBIT 4.1 tm218254d6_ex4-1.htm EX-4.1 818432
4 EXHIBIT 12.1 tm218254-5_exh12x1.htm EX-12.1 11683
5 EXHIBIT 12.2 tm218254-5_exh12x2.htm EX-12.2 11964
6 EXHIBIT 13.1 tm218254-5_exh13x1.htm EX-13.1 4833
7 EXHIBIT 13.2 tm218254-5_exh13x2.htm EX-13.2 4864
8 EXHIBIT 16.1 tm218254-5_exh16x1.htm EX-16.1 7604
9 EXHIBIT 23.1 tm218254-5_exh23x1.htm EX-23.1 3148
10 EXHIBIT 23.2 tm218254-5_exh23x2.htm EX-23.2 5661
11 GRAPHIC tm218254d1-tbl_ourprod4clr.jpg GRAPHIC 87707
  Complete submission text file 0001104659-21-039129.txt   2018273
Mailing Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000
Business Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000 4588773600
Zealand Pharma A/S (Filer) CIK: 0001674988 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-38178 | Film No.: 21758660
SIC: 2834 Pharmaceutical Preparations